The PHARM Connect Congress - Kongres PHARM Connect- Najlepsze Wydarzenie Farmaceutyczne i Biotechnologiczne w Europie Środkowo- Wschodniej
linkedin
facebook
Twitter
Youtube
 
Po raz 8, 13-14 marca 2018  
*****Corinthia Hotel Budapeszt, Węgry Zaloguj się do harmonogramu spotkań demo CZE ENG HUN POL ROU
  1. PHARM Connect
  2. Program
  3. Nagrody
  4. Video
  5. Wiadomości
vr

PHARM Connect

Kongres PHARM Connect

Kongres PHARM Connect jest największym i najważniejszym farmaceutycznym i biotechnologicznym szczytem biznesowym w Europie Środkowej i Wschodniej oraz w regionie WNP, który corocznie odbywa się w lutym w Budapeszcie.

Od rozpoczęcia organizacji pierwszej edycji w 2011 roku, liczba uczestników osiągnęła ponad 500 z ponad 20 krajów w regionie i poza nim. W ciągu dwóch dni Kongresu wiodący dostawcy usług z sektora farmaceutycznego i biotechnologicznego - obejmujący szeroki zakres profili od produkcji API i zamówień kontraktowych do przetwórstwa, biofarmaceutycznych rozwiązań, biofarmaceutyków, systemów dostarczania leków, zachowania czystości miejsca pracy, sprzętu laboratoryjnego, monitoringu i systemu kontroli, kontroli jakości, pakowania i etykietowania, automatyki, inżynierii i strategii w utrzymaniu ruchu, logistyki, magazynowania, dystrybucji i zimnego łańcucha dostaw do magazynowania i wielu innych – uczestnicy mają unikalną okazję spotkać najważniejszych brażowych decydentów z celowych spółek.

 

Elitaryzm

Warunkiem wzięcia udziału w Kongresie jest otrzymanie zaproszenia, które gwarantuje najwyższy poziom delegacji. Każdy dostawca usług biorący udział w PHARM Connect jest wybierany w oparciu o potrzeby i zainteresowania określone z wyprzedzeniem przez uczestników

 

Najbardziej aktualne dane rynkowe

W celu zapewnienia wysokiej jakości programu konferencji, ściśle współpracujemy z wiodącymi lokalnymi i regionalnymi stowarzyszeniami, europejskimi i międzynarodowymi partnerami medialnymi oraz z naszym Komitetem Doradczym Programu, którego członkowie to znani i cenieni eksperci farmaceutyczni i biofarmaceutyczni z wiodących międzynarodowych firm. Program konferencji obejmuje najbardziej aktualne dane rynku w zakresie: badań i rozwoju, produkcji, inżynierii, zarzania łańcuchem dostaw i tematy związane z zarządzaniem jakością.

Wcześniej zaplanowane spotkania biznesowe

Przez dwa dni podczas trwania zaaranżowanych z wyprzedzeniem spotkań biznesowych one-to-one, oraz innych działań networkingowych, wystawcy mają okazję spotkać się z osobami decyzyjnymi  zwiększając tym samym wydajność firmy, tworząc wyjątkową okazję do rozwijania znaczących i wartościowych relacji biznesowych.

Kongres oferuję także niepowtarzalną okazję do wzięcia udziału w specjalnie zorganizowanych wizytacjach do zakładów produkcyjnych w celu zapoznania się z głównymi producentami farmaceutycznymi w regionie- harmonogram ustalany jest przed rozpoczęciem Kongresu i jest dostępny w Meeting Scheduler.

Pięciogwiazdowa lokalizacja

Najlepszy biznes osiąga się zawsze w doskonałym i sprzyjającym otoczeniu, dlatego nasz Kongres organizujemy w luksusowym pięciogwiazdkowym Corinthia Grand Hotel w centrum Budapesztu.

Wiadomości

03/01/2017

Interview with Meditop

Interview with Meditop In 2017 at PHARM Connect Meditop Pharmaceutical Ltd. won the 3rd CEE Pharmaceutical Manufacturing Excellence Award in the manufacturer category by developing an innovative approach to improve film coating efficiency with developing and applying of a continuous film coater.

Read more

03/01/2017

Interview with Blulog

Interview with Blulog In 2017 at PHARM Connect Blulog won the 3rd CEE Pharmaceutical Manufacturing Excellence Award in the solution provider category by developing an innovative solution for temperature and humidity monitoring and produced NFC connected boxes to assure the wireless and precise temperature and humidity monitoring during drug transportation.

Read more

Subskrybcja newsletter'a

Będziemy Państwa informować na bierząco w sprawach dotyczących Konferencji oraz programu. 

Jeśli chcą Państwo otrzymywać więcej informacji dotyczących Konferencji PHARM Connect, prosimy o zasubskrybowanie naszego newsletter'a here przeszłając nam swój adres e-mailowy wpisując w temacie wiadomości "subskrybcja".

Dziękujemy za zainteresowanie.

 

Jeśli nie chcą Państwo dłużej otrzymywać od nas newsletter'a, prosimy o przesłanie "usunięcie subskrybcji" w temacie wiadomości swojego e-maila. 

video

PHARM Connect Congress 2016 LIVE

TEG The Events Group

video

PHARM Connect 2015 LIVE

TEG The Events Group

video

PHARM Connect 2015

One-to-One interview with Terry Siggins, GE IP

Nagrody

Videojet Technologies received the 2nd Central Eastern European Pharmaceutical Manufacturing Excellence Award in 2016

 

TEG with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) handed out the 2nd Central Eastern European Pharmaceutical Manufacturing Excellence Award in 2016 to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. The award was handed out at the award ceremony at the PHARM Connect Congress 2016 in Budapest.

The 2nd Central Eastern European Pharmaceutical Manufacturing Excellence Award ceremony together with the cocktail reception was opened by Dr. Lajos Hegedüs former Managing Director of Teva Pharmaceuticals Hungary and now the Chairman of the Production Commission at MAGYOSZ who announced the winner and handed out the award to Videojet Technologies, emphasising that these tried method will encourage professionals to constantly raise standards and come up with outstanding manufacturing excellence solutions, to further contribute to the development of the rapidly growing CEE region.

In the picture: Dr. Lajos Hegedűs, Chairman Production Commission, MAGYOSZ


The jury selected the joint winner for the following reasons:

  • Videojet winner designed a Thermal inject printer for integration into complex track and trace lines.
  • In cooperation with a solution provider company they conducted comprehensive trials to confirm the product’s    suitability in terms of integration, performance and control.
  • Several new innovative features had been built into the product. To meet certain physical constrains the printer is 60% smaller than comparable legacy print controllers. It offers a range of possibilities for secure integration. It offers innovative, new possibilities to add surplus print-heads. The product fitted with a display for presenting machine diagnostics, but with no ability to input data or to access printer control to avoid operator interference or errors.
  • Due to the built-in productivity improvements the new printer reduces ink consumption, reduce line stops and changeovers, reduce operator error and improve operational security.

 

In the picture: Chris Schneider, Global Product Manager Pharma and Heidi Vanheerswynghels, Sales Manager EMEA – Healthcare at Videojet Technologies Inc.

 


SPECIAL THANKS to the 2016 jury members who evaluated the applications by their level of level of cost-effectiveness, quality, service and innovation


 

Dr. Lajos Hegedűs

former General Manager 

TEVA

Chairman Production Commission  

MAGYOSZ

 

István Király

Managing Director

GSK Biologicals


Endre Kollár

Associate Vice President, Director of Germany-Hungary-India-Italy Production Group

Sanofi

Dr. Erik Bogsch    


Head of Biotechnology R&D Division

 

Gedeon Richter

 

If you think your solution is cutting-edge and should be recognised by the industry, apply now for the

3rd CEE Pharmaceutical Manufacturing Excellence Award until the 16th of January 2017 

and put your business in the spotlight!


For further details regarding the application for the 3rd CEE Pharmaceutical Manufacturing Excellence Award please click here or contact 

Katy Säurich, Head of Production & Operations at TEG

Tel:        + 36 1 219-5725 
Email:    KatyS@tegevents.eu

Program

PHARM Connect Congress 2018 will bring you an overview of the Central Eastern European market and the main trends and impacts on the pharmaceutical manufacturing & biotechnology world.

For speaking opportunities please contact

Katy Säurich

Operations & Production Manager at TEG

Email: katys@tegevents.eu | Tel: + 36 1 219-57


 PHARM CONNECT 2017 SPEAKERS

Opening Keynote Presesntation:

TERROSA - First Biosimilar Approval for Gedeon Richter  

• Key development steps for biosimilars

• Technology platforms applied

• Medical device aspects

• Clinical development programme challenges of biosimilars

• A complex IP landscape

• Market access challenges

Dr. Erik Bogsch, Head of Biotechnology R&D, Gedeon Richter

Dr. Ildikó Aradi, Head of Clinical Development of Biologics, Gedeon Richter

Dr. Katalin Fogassy, TERROSA Project Manager, Gedeon Richter

Keynote Presentation:

EU’s Falsified Medicines Directive (FMD): How to prepare now for the 2019 deadline?

• Preparing for compliance: How to protect the market?

• Global look at Big Pharma business-critical practicalities of serialisation

• GSK best practice case study and lessons learnt

Neil Lawrence

Global Serialisation Champion, Global Manufacturing and Supply, GlaxoSmithKline

Case Study Presentation:

New Equipment and Equipment Substitutes – Best Practices of Integration and Process Validation

• Considerations during tablet press substitution: how to integrate the new machine into the existing production system and how to validate operation

• How to handle differences and analogies

• Incorporation of technical improvements into the production process

Dr. János Dombovári

Director Operational Excellence Pharma Division, TEVA Pharmaceuticals Works

Presentation:

Regulatory and quality management system changes in Russian Pharma market: Recent developments and future perspective

The impact of main regulatory requirements on drugs turnover

•  Local clinical trials,Russian GMP inspections

•  State quality control system

•  Price regulation

Eurasian Union pharmaceutical market. What exactly was introduced and what are the expectations?

Ekaterina Tvorogova

Regulatory Affairs Manager, Egis Pharmaceuticals, Representation in Russia

Case Study Presentation:

Challenges in meeting Good practices for data management and integrity in regulated GMP environments guidance

• General requirements related to data integrity

• Main FDA and EU inspections observations in scope of data management and integrity

• Data management and Integrity program for pharmaceutical company

Dr. Piotr Lipinski

Quality Systems Manager/QP, Novartis Technical Operations - Platform Solids Europe, Lek / Novartis

Presentation:

Concepts to improve the productivity of drug innovation

• Trends in performance of drug innovation, an overview

• Limitations of productivity

• Some principles for (more) effective preclinical research

• The possible contributions of University to drug discovery

• Case studies

Professor Péter Mátyus

Director of the Drug Discovery and Safety Centre and CEO of the Bionics Innovation Center, Semmelweis University Budapest

Presentation:

„Spread the Word”

• How are the fake drugs distributed?

• Who buys on the internet?

• How to inform the customers about the risk?

• Program for generation Z

• What is their reflection?

Dr. Lívia Ilku 

Director

Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ)

 

Erzsébet Ódor

 Country Security Partner, SANOFI

Head of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) Environment Subcommittee

Case Study Presentation:

Industry 4.0 and Single Use Technology in BioPharma

• The 4th Industrial Revolution

• Improving Competitiveness

• Impact for BioPharma

• Continuous Manufacturing

• Examples of implemented Smart Factories

Dirk Tillich

VP Global Sales, Core Business, Finesse Solutions

Case Study Presentation:

Discover Pall’s full mAb Purification Platform

The presentation illustrates recent evolutions in Bioprocessing and describes in detail all potential opportunities for a process platform run in continuous mode. The content rounds up with an overview of selected Pall products and gives useful application details in Downstream Processing.

Adriane Raninger

Bio-Purification Process Specialist CEE, Pall Life Sciences

Case Study Presentation:

Efficiency increase for single-use cell removal (Midstream) using filter aid and continuous process design

• Increasing cell removal efficiency

• Continuous process

• Cost effective process

Ralph Daumke

Market Manager Biologics, FILTROX

  PANEL DISCUSSION DAY 1

 EU’s Falsified Medicines Directive (FMD): How to protect the market?

Grzegorz Brzoskowski

Security Director CEE / Baltic, SANOFI

Réka Balogh

Serialization Project Coordinator, QA Expert, TQM, Gedeon Richter

Leader of the Hungarian Pharmaceutical Manufacturers Association(MAGYOSZ) Safety Feature Committee

Neil Lawrence

Global serialization Champion,Global Manufacturing and Supply, GlaxoSmithKline

 

 PANEL DISCUSSION DAY 2

 Regulatory and quality management system changes in Russian & Ukrainian Pharma market

 Introductory speech by Dr. Sergii Sur, Regulatory Affairs Director, Arterium Corporation

Dr. Herta Pálfi Goóts

Director, Regulatory Affairs, Gedeon Richter

Head of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) Regulatory Affairs Committee

Dr. Sergii Sur

Regulatory Affairs Director, Arterium Corporation

Ekaterina Tvorogova

Drug Regulatory Affairs Manager, EGIS Pharmaceuticals, Representation in Russia

 PROJECT PRESENTATIONS BY THE AWARD WINNERS
The award has been established to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. Manufacturers as well as solution providers were welcome to apply with their most innovative projects and methods implemented in the region. The winners had the opportunity to present their projects at PHARM Connect 2017.

Presentation of the Award Winner in the Solution Provider Category

In 2017 at PHARM Connect Blulog won the 3rd CEE Pharmaceutical Manufacturing Excellence Award in the solution provider category by developing an innovative solution for temperature and humidity monitoring and produced NFC connected boxes to assure the wireless and precise temperature and humidity monitoring during drug transportation.

Jeremy Laurens, Sales and Marketing Director, Blulog

 

Presentation of the Award Winner in the Manufacturer Category

In 2017 at PHARM Connect Meditop Pharmaceutical Ltd. won the 3rd CEE Pharmaceutical Manufacturing Excellence Award in the manufacturer category by developing an innovative approach to improve film coating efficiency with developing and applying of a continuous film coater.

Dr. János Bajdik, Head of Pharmaceutical Laboratory, Meditop

 


 ADDITIONAL ACTIVITIES
 

PRE-EVENT PROGRAMME | 21st February 2017

Site visit to the GlaxoSmithKline Biologicals plant

The congress provides the opportunity to visit GlaxoSmithKline Biologicals in Gödöllő; this is limited for 50 delegates only and available on a complimentary, first-come, first-served basis at 13:00 on 21st February.

GlaxoSmithKline Biologicals Kft. is located in Gödöllő and is part of the GlaxoSmithKline Vaccines business branch. At the Gödöllő site GSK is producing, testing and releasing Tetanus and Diphtheria bulk antigens for shipment to other GSK Vaccines sites. About 220 people are involved in the manufacturing of antigens used in vaccines such as Synflorix™, Menitorix™, Hiberix™, and MenHibrix™. The Gödöllő site contributes 12% to the annual turnover of GSK Vaccines.

The visit of the site will provide an opportunity to get more information about the activities of the Gödöllő site, the vaccine manufacturing process and the manufacturing facility of the biotechnology site. The site visit will start with an introduction of the GSK Vaccines business division and the Gödöllő site, including a short movie about the activities which is followed by a site tour including a visit to the manufacturing facility.

Delegates can select among the following three focus groups:

• Group A: production corridor, Biochemistry lab and warehouse

• Group B: warehouse, production corridor, Microbiology lab

• Group C: Microbiology lab, warehouse and production corridor

As for the outfit, jeans and comfortable shoes are required. Helmet is needed in warehouse, gowning (coat) in Biochemistry lab, gowning (coat) and shoe cover are needed in the Micobiology lab and will be provided before the visit.

TRANSFER: The bus will leave in front of the Corinthia Grand Hotel Royal on February 21st at 12:00 p.m. and will return after the visit at approximately 5:00 p.m.

POST-EVENT PROGRAMME | 23rd February 2017

Site visit to the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK)

The congress provides the opportunity to visit the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK) in Budapest; this is limited for 60 delegates only and available on a complimentary, first-come, first-served basis at 17:00 on 23rd February. The MTA Research Centre for Natural Sciences carries out multidisciplinary research in natural sciences.

Priorities are given to the following disciplines:

• Organic chemistry

• Materials- and environmental chemistry

• Molecular and cellular life sciences

• Cognitive neuroscience and psychology

The visit will start with a short, introductory presentation about the MTA TTK. Afterwards, the delegates will have the opportunity to choose a tour to the four research institutes:

Organic chemistry

Developing novel types of reaction, the synthesis of new ring frames and compounds in the field of organic small- and supramolecular molecules, determination of chemical structure and interpretation of experimental processes by instrumental techniques and theoretical calculations.

Materials- and environmental chemistry

Research of discovery and experimental development in some key areas of materials- and environmental science, with special emphasis on chemical aspects thereof. Exploratory research in the field of nanoscale functional materials and application of the results in integrated nano/micro systems.

Enzymology

Researchers at the Institute of Enzymology investigate the structure of proteins and how they function – at the level of molecules through to complex organisms. They make use of the latest biochemical, imaging and genetic engineering methods to reveal the structure of proteins, their properties and the biological functions enzymes perform in the human body. Further important areas of research are signal processing and transmission, the regulation of protein breakdown and how cancer evolves. The researchers also want to find out what the actual protein composition of the cell looks like and how complete biological systems function. Target-based drug development.

Cognitive neuroscience and psychology

Research of discovery and applications in experimental psychology, human-, developmental and comparative psychophysiology, social development psychology, social psychology and cultural psychology.

TRANSFER: The bus will leave in front of the CORINTHIA Grand Hotel Royal on February 23rd at 4:00 p.m. and will return after the visit at approximately 8:00 p.m.


vr
Sponsorzy
vr
Pall Life Sciences
Finesse Solutions
FILOTROX
Bird & Bird

Exclusive Legal Partner

Meditop

Exclusive Excursion Partner

MTA TTK

Exclusive Excursion Partner

View_further_vendors

vr
Przykładowa lista sponsorów
vr

View_further_vendors

vr
vr

View more

vr
Partnerzy medialni
vr
Exclusive Hungarian Media Partner
MarketingPirula- PirulaTrend

View more

vr

Kongres PHARM Connect- Najlepsze Wydarzenie Farmaceutyczne i Biotechnologiczne w Europie Środkowo- Wschodniej

vr

map

vr
| | Kontakt | Zarezerwuj teraz
TheEventsGroup © 2012 | Polityka prywatności |
Design: Nortyx Program: Nortyx Web and Recording studio, Stage technic